ROCKII Ser1366 phosphorylation reflects the activation status

Area of Science:

• Molecular Biology
• Cell Signaling
• Biochemistry

Background:

• Rho-associated protein kinase (ROCK) is a key regulator of cellular processes and implicated in various diseases.
• Direct detection of ROCK activation is currently limited, hindering research into its role in pathogenesis.
• ROCKII, a specific isoform, is a crucial downstream effector of RhoA signaling.

Purpose of the Study:

• To develop a novel reagent for directly detecting ROCKII activation.
• To identify and validate a specific phosphorylation site indicative of ROCKII kinase activity.
• To establish a method for assessing ROCKII activation status in biological samples.

Main Methods:

• In vitro kinase assays to study ROCKII autophosphorylation.
• Mass spectrometry (MS) for identification of phosphorylation sites.
• Generation and validation of a phospho-specific antibody against ROCKII Ser1366.
• Immunohistochemical staining of human breast tumors.

Main Results:

• ROCKII undergoes autophosphorylation, with Ser1366 identified as a major phosphorylation site.
• A phospho-specific antibody successfully recognized ROCKII Ser1366 phosphorylation.
• Endogenous ROCKII Ser1366 phosphorylation levels correlated with RhoA stimulation and myosin light chain phosphorylation.
• ROCKII Ser1366 phosphorylation was detectable in human breast tumors via immunohistochemistry.

Conclusions:

• ROCKII Ser1366 phosphorylation serves as a reliable indicator of its kinase activity.
• The developed phospho-specific antibody provides a direct method to assess ROCKII activation.
• This approach facilitates the study of ROCKII's role in disease pathogenesis and its potential as a therapeutic target.